mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.06 |